Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
100.00%
Operating Margin
22.49%
Net Margin
448.00%

Efficiency Metrics

Revenue per Expense Ratio
1.23
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
451.55%
Income Tax Rate
0.00%
EPS
2.1800000000

Balance Sheet Analysis

Current Ratio
2.29
Cash Ratio
0.82
Working Capital
$989.98K
Debt to Equity
0.00
Debt to Assets
0.00%
Equity Ratio
99.27%

Cash Flow Analysis

Operating Cash Flow Ratio
0.00%
Free Cash Flow Ratio
0.00%
CapEx to Revenue
0.00%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
0.00%

Key Takeaways (2023 FY)

  • Revenue declined by 69.754352781103%, indicating potential market challenges
  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
-69.75%
Net Income
70.84%
EPS
74.40%
Operating Income
-91.42%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
94.57%
Operating Cash Flow
0.00%
Free Cash Flow
0.00%

Balance Sheet Health

Assets
6.60%
Debt
0.00%
Book Value per Share
8.36%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
0.00%
Shares Outstanding
-1.93%

Long Term Trends

3Y Revenue/Share
-97.99%
5Y Revenue/Share
110.64%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%